Preview

PDF 140592 - how do...pdf | Download (101kB) | Preview

Abstract

The COVID-19 pandemic has brought concurrent challenges. The increased incidence of fake and falsified product distribution is one of these problems with tremendous impact, especially in low- and middle-income countries. Up to a tenth of medicines including antibiotics and antimalarial drugs in the African market are considered falsified. Pandemics make this worse by creating an ecosystem of confusion, distraction, and vulnerability stemming from the pandemic as health systems become more stressed and the workload of individuals increased. These environments create opportunities for substandard and falsified medicines to be more easily introduced into the marketplace by unscrupulous operators. In this work, we discussed some of the challenges with fake or falsified product distribution in the context of COVID-19 and proposed strategies to best manage this problem.

Item Type:	Article
Authors/Creators:	Tesfaye, WH and Abrha, S and Sinnollareddy, M and Arnold, B and Brown, A and Matthew, C and Oguoma, VM and Peterson, GM and Thomas, J
Keywords:	counterfeit medicines, fake, malaria, standards safety
Journal or Publication Title:	American Journal of Tropical Medicine and Hygiene
Publisher:	Amer Soc Trop Med & Hygiene
ISSN:	0002-9637
DOI / ID Number:	10.4269/ajtmh.20-0903
Copyright Information:	Copyright 2020 by The American Society of Tropical Medicine and Hygiene. Licensed under Creative Commons Attribution 4.0 International (CC BY 4.0) https://creativecommons.org/licenses/by/4.0/
Related URLs:	UTAS Profile: Peterson, GM
Item Statistics:	View statistics for this item

Actions (login required)

Item Control Page